163 related articles for article (PubMed ID: 23810664)
1. Effect of metformin on prostate cancer outcomes after radical prostatectomy.
Kaushik D; Karnes RJ; Eisenberg MS; Rangel LJ; Carlson RE; Bergstralh EJ
Urol Oncol; 2014 Jan; 32(1):43.e1-7. PubMed ID: 23810664
[TBL] [Abstract][Full Text] [Related]
2. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Metformin Against Biochemical Failure Following Radical Prostatectomy or Radiation Therapy in Localized Prostate Cancer.
Huynh LM; Keit E; Huang E; Carrillo RC; Ahlering TE; Boyle S; Enke CA; Baine M
Urology; 2021 Sep; 155():172-178. PubMed ID: 33515557
[TBL] [Abstract][Full Text] [Related]
4. Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
Allott EH; Abern MR; Gerber L; Keto CJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Moorman PG; Freedland SJ
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):391-7. PubMed ID: 24100644
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
[TBL] [Abstract][Full Text] [Related]
6. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer.
Rieken M; Kluth LA; Xylinas E; Fajkovic H; Becker A; Karakiewicz PI; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Pummer K; Lee RK; Faison T; Scherr DS; Kautzky-Willer A; Bachmann A; Tewari A; Shariat SF
World J Urol; 2014 Aug; 32(4):999-1005. PubMed ID: 24062093
[TBL] [Abstract][Full Text] [Related]
7. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
Ritch CR; You C; May AT; Herrell SD; Clark PE; Penson DF; Chang SS; Cookson MS; Smith JA; Barocas DA
Urology; 2014 Jun; 83(6):1309-15. PubMed ID: 24746665
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: a detailed assessment of margin extent and location.
Sammon JD; Trinh QD; Sukumar S; Ravi P; Friedman A; Sun M; Schmitges J; Jeldres C; Jeong W; Mander N; Peabody JO; Karakiewicz PI; Harris M
Urol Oncol; 2013 Nov; 31(8):1470-6. PubMed ID: 22534086
[TBL] [Abstract][Full Text] [Related]
9. Surgical margin length and location affect recurrence rates after robotic prostatectomy.
Dev HS; Wiklund P; Patel V; Parashar D; Palmer K; Nyberg T; Skarecky D; Neal DE; Ahlering T; Sooriakumaran P
Urol Oncol; 2015 Mar; 33(3):109.e7-13. PubMed ID: 25512161
[TBL] [Abstract][Full Text] [Related]
10. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
11. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A
BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270
[TBL] [Abstract][Full Text] [Related]
12. Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy.
Ha YS; Kang DI; Kim JH; Joung JY; Yu J; Parihar JS; Salmasi AH; Horie S; Kim WJ; Yi Kim I
Can J Urol; 2014 Jun; 21(3):7290-7. PubMed ID: 24978359
[TBL] [Abstract][Full Text] [Related]
13. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
[TBL] [Abstract][Full Text] [Related]
14. Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database.
Aminsharifi A; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Polascik TJ; Freedland SJ
Clin Genitourin Cancer; 2019 Feb; 17(1):e140-e149. PubMed ID: 30366879
[TBL] [Abstract][Full Text] [Related]
15. Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era.
Fairey AS; Daneshmand S; Skinner EC; Schuckman A; Cai J; Lieskovsky G
Urol Oncol; 2014 Feb; 32(2):85-91. PubMed ID: 24183191
[TBL] [Abstract][Full Text] [Related]
16. Aetiology and management of earlier vs later biochemical recurrence after retropubic radical prostatectomy.
Llukani E; Lepor H
BJU Int; 2017 Oct; 120(4):505-510. PubMed ID: 28220652
[TBL] [Abstract][Full Text] [Related]
17. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
18. Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes.
Danzig MR; Kotamarti S; Ghandour RA; Rothberg MB; Dubow BP; Benson MC; Badani KK; McKiernan JM
Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):63-8. PubMed ID: 25403419
[TBL] [Abstract][Full Text] [Related]
19. Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.
Barzi A; Lara PN; Tsao-Wei D; Yang D; Gill IS; Daneshmand S; Klein EA; Pinski JK; Penson DF; Quinn DI; Sadeghi S
Cancer; 2019 Nov; 125(21):3853-3863. PubMed ID: 31398279
[TBL] [Abstract][Full Text] [Related]
20. Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy.
Takeuchi N; Sakamoto S; Nishiyama A; Horikoshi T; Yamada Y; Iizuka J; Maimaiti M; Imamura Y; Kawamura K; Imamoto T; Komiya A; Ikehara Y; Akakura K; Ichikawa T
Clin Genitourin Cancer; 2018 Aug; 16(4):e817-e829. PubMed ID: 29576444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
